SG HealthCare Co., Ltd. (KOSDAQ:398120)
South Korea · Delayed Price · Currency is KRW 2,300.00
0.00 (0.00%)
At close: Oct 8, 2026
SG HealthCare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | 25,956 | 24,601 | 16,105 | 27,779 | 25,499 |
Other Revenue | -0 | -0 | - | -0 | -0 |
| 25,956 | 24,601 | 16,105 | 27,779 | 25,499 | |
Revenue Growth | 91.56% | 52.76% | -42.02% | 8.94% | - |
Cost of Revenue | 17,754 | 17,517 | 10,968 | 20,687 | 19,344 |
Gross Profit | 8,202 | 7,084 | 5,136 | 7,091 | 6,155 |
Selling, General & Admin | 5,151 | 4,261 | 4,289 | 3,852 | 3,672 |
Research & Development | 939.57 | 888.22 | 681.85 | 557.34 | 517.39 |
Amortization of Goodwill & Intangibles | 0.74 | - | 1.62 | 1.46 | 1.45 |
Other Operating Expenses | 41.08 | 5.59 | 4.07 | 5.93 | 8.74 |
Operating Expenses | 6,589 | 5,617 | 5,809 | 4,844 | 4,396 |
Operating Income | 1,612 | 1,467 | -673.1 | 2,248 | 1,759 |
Interest Expense | -369.02 | -385.16 | -483.91 | -1,017 | -1,509 |
Interest & Investment Income | 136.83 | 146.91 | 135.66 | 122.96 | 56.79 |
Earnings From Equity Investments | 16.38 | - | - | -0.91 | -1.15 |
Currency Exchange Gain (Loss) | 882.58 | -214.81 | 936.02 | 129.77 | 67.54 |
Other Non Operating Income (Expenses) | -955.04 | -10.04 | -3,475 | 716.86 | -641.05 |
EBT Excluding Unusual Items | 1,324 | 1,004 | -3,561 | 2,199 | -267.75 |
Gain (Loss) on Sale of Investments | 32.23 | 32.23 | -10.27 | - | -1.36 |
Gain (Loss) on Sale of Assets | - | -4.13 | -71.42 | - | 1.53 |
Asset Writedown | 3 | 5 | -13 | -84.13 | - |
Pretax Income | 1,359 | 1,037 | -3,655 | 2,115 | -267.57 |
Income Tax Expense | 300.14 | 102.26 | -122.31 | 339.19 | 183.37 |
Earnings From Continuing Operations | 1,059 | 935.05 | -3,533 | 1,776 | -450.94 |
Minority Interest in Earnings | 42.03 | 0.55 | -14.42 | -9.22 | - |
Net Income | 1,101 | 935.6 | -3,547 | 1,767 | -450.94 |
Net Income to Common | 1,101 | 935.6 | -3,547 | 1,767 | -450.94 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 11 | 11 | 9 | 8 | 6 |
Shares Outstanding (Diluted) | 11 | 11 | 9 | 8 | 6 |
Shares Change | 39.00% | 19.80% | 18.98% | 28.47% | - |
EPS (Basic) | 98.37 | 85.92 | -386.00 | 228.74 | -75.00 |
EPS (Diluted) | 97.33 | 85.00 | -386.00 | 228.74 | -75.00 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 1,354 | -5,936 | -2,936 | -432.66 | -1,946 |
Free Cash Flow Per Share | 119.61 | -539.13 | -319.44 | -56.01 | -323.67 |
Gross Margin | 31.60% | 28.80% | 31.89% | 25.53% | 24.14% |
Operating Margin | 6.21% | 5.96% | -4.18% | 8.09% | 6.90% |
Profit Margin | 4.24% | 3.80% | -22.03% | 6.36% | -1.77% |
Free Cash Flow Margin | 5.21% | -24.13% | -18.23% | -1.56% | -7.63% |
EBITDA | 2,412 | 2,107 | -303.9 | 2,552 | 2,055 |
EBITDA Margin | 9.29% | 8.56% | -1.89% | 9.19% | 8.06% |
D&A For EBITDA | 799.28 | 639.51 | 369.2 | 303.78 | 295.63 |
EBIT | 1,612 | 1,467 | -673.1 | 2,248 | 1,759 |
EBIT Margin | 6.21% | 5.96% | -4.18% | 8.09% | 6.90% |
Effective Tax Rate | 22.08% | 9.86% | - | 16.04% | - |
Advertising Expenses | - | 149.74 | 188.65 | 267.8 | 354.32 |